All Posts By

Smartkarma Press

ZTE Rilis Solusi SuperDSS yang Pertama di Industri untuk “Tri-RAT Dynamic Spectrum Sharing”

By | ID, PR

SHENZHEN, Tiongkok, 19 Februari 2020 /PRNewswire/ — ZTE Corporation (0763.HK / 000063.SZ), vendor terkemuka di dunia untuk solusi telekomu-nikasi, teknologi bagi kalangan perusahaan dan konsumen dalam sektor Inter-net Seluler (Mobile Internet), pada hari ini merilis solusi SuperDSS, solusi per-tama di industri untuk tri-RAT dynamic spectrum sharing. Peluncuran solusi ini menjadi lompatan inovasi penting bagi solusi Magic Radio Pro di era 5G. Su-perDSS ingin mewujudkan multi-RAT spectrum sharing ketika pita frekuensi FDD yang ada diperbarui (refarmed) untuk 5G. Lebih lagi, SuperDSS mampu mewujudkan dynamic spectrum sharing baik bagi jaringan 2G/4G/5G dan 3G/4G/5G. SuperDSS juga menjadi cara ideal untuk pemasangan 5G secara cepat, dan di saat bersamaan, menawarkan layanan telepon yang telah ada dengan pita frekuensi di atas 1.800 MHz atau 2.100 MHz. Dengan demikian, imbal hasil atas investasi untuk spektrum komunikasi dapat dimaksimalkan.

ZTE mengandalkan berbagai teknologi mutakhir dan pengalaman luasnya da-lam implementasi komersial di bidang spectrum sharing. Dengan kedua hal ini, ZTE meluncurkan solusi tri-RAT dynamic spectrum sharing sebagai ba-gian dari solusi andalannya, Magic Radio Pro, demi melengkapi solusi dual-RAT. Lebih lagi, ZTE menawarkan fleksibilitas yang jauh lebih luas bagi ka-langan operator untuk pemasangan 5G. Dengan demikian, ZTE kembali memimpin inovasi teknologi di sektor tersebut.

SuperDSS ZTE mendukung full dynamic sharing untuk 2G/4G/5G atau 3G/4G/5G secara sekaligus pada pita frekuensi di atas 1.800 MHz atau 2.100 MHz sehingga bisa dipakai jaringan 2G atau 3G berdasarkan kebutuhan (on demand). Hal ini dilakukan sambil menghadirkan sebanyak mungkin sumber daya spektrum bagi jaringan LTE dan NR. Kedua jaringan tersebut mena-warkan layanan telepon yang telah tersedia dan layanan 5G secara seim-bang. Menjadikan bandiwith 20 MHz sebagai contoh, setidaknya satu opera-tor UMTS dialokasikan untuk kebutuhan panggilan telepon oleh pengguna UMTS. Jadi, 4G/5G DSS hanya dapat dipakai pada bandwidth 15 MHz, se-dangkan, dengan memakai ZTE SuperDSS, jaringan 3G, 4G dan 5G se-luruhnya dapat dibagikan pada bandwidth 20 MHz. Lalu, bandwidth operator UMTS juga bisa diatur secara seketika berdasarkan kebutuhan layanan.

Solusi ZTE Magic Radio Pro merupakan solusi multi-RAT dynamic spectrum sharing yang paling lengkap, dan menawarkan dynamic spectrum sharing hingga tujuh skenario penggunaan dengan lima teknologi radio access (GSM, UMTS, LTE, NB-IoT dan NR). Sebagai pemimpin inovasi di sektor ini, ZTE te-lah berpengalaman luas dalam menyediakan solusi multi-RAT dynamic spec-trum sharing sejak 2014. ZTE turut membantu kalangan operator untuk meningkatkan pengalaman pengguna dan daya saing pasar. Di samping itu, ZTE membantu kalangan operator untuk mengakhiri pemakaian sejumlah teknologi lama dan menerapkan teknologi baru sehingga efisiensi investasi tampil jauh lebih baik.

ZTE merupakan vendor berbagai sistem telekomunikasi canggih, perangkat seluler, dan solusi teknologi untuk keperluan bisnis (enterprise technology) bagi para konsumen, operator telekomunikasi, perusahaan, serta instansi pemerintah. Sebagai bagian dari strateginya, ZTE berkomitmen menyediakan berbagai inovasi terpadu dan lengkap (end-to-end) bagi para pelanggan demi menghadirkan keunggulan dan nilai bisnis seiring dengan persinggungan sektor telekomunikasi dan teknologi informasi. Terdaftar di bursa efek Hong Kong dan Shenzhen (kode saham di bursa efek Hong Kong: 0763.HK / kode saham di bursa efek Shenzhen: 000063.SZ), ZTE menjual berbagai produk dan layanannya di lebih dari 160 negara.

Narahubung bagi Media:
Margaret Ma
ZTE Corporation
Tel: +86 755 26775189
Surel: [email protected]

Related Links :

www.zte.com.cn

Are you a Corporate Representative of ZTE Corporation, an investor, or a member of the Business Press?



New Clarivate Analytics Report Reveals Emergence of Market Disrupters is Fragmenting Global Patent Landscape, Diluting Leading Innovators’ Invention Market Share

By | EN, PR

Innovation becoming more knowledge-intense and collaborative while the average number of inventors per patent record(1) rises according to latest Derwent Top 100 Global Innovators report

LONDON and PHILADELPHIA, Feb. 19, 2020 /PRNewswire/ — The global innovation environment is rapidly fragmenting as large organizations(2), share of global inventions drops to 18% in the face of competition from market disruptors. This is according to the Derwent Top 100 Global Innovators 2020 report, released today by Clarivate Analytics Plc (NYSE:CCC; CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation.

The annual report, which can be downloaded here, identifies the world’s most innovative organizations. These businesses have successfully developed valuable patented inventions that also have strong commercialization potential based on market reach and impact on other downstream inventions.

For the first time, in 2020, the report’s analysis extends beyond the Top 100 to reveal three key trends:

  • Top 1,000’s shrinking invention market share: Six years ago, over a quarter (27%) of all inventions in Derwent World Patents Index™ (DWPI) came from the top 1,000 entities. Today, this has decreased to 18%. More and more patents are being incubated in smaller companies or even individual entrepreneurs and inventors. Large companies must learn to collaborate better and explore non-traditional partnerships or risk falling behind.
  • The need for collaboration: Innovation is becoming more knowledge intensive, and as technologies converge, base science, and engineering disciplines are more often combined, thereby requiring multiple layers of expertise. This is evident in the increase in the average number of listed inventors per DWPI patent record from 2.84 (in 2014) to 2.99 (in 2019).
  • Compression at the top: The threshold score for inclusion in the Derwent Top 100 Global Innovators has increased by over one-fifth (22% over a six-year period). The six new entrants to the Derwent Top 100 Global Innovators this year –Fujikura, HTC, Immersion, Microchip, Schneider Electric, and Tencent – have successfully navigated today’s competitive innovation landscape, and on average risen 250 places in the rankings since 2015.

"Today’s modern inventions, from phones and electric vehicles to medical devices, all require deeper and broader expertise, and for previously unrelated disciplines to work together," said Ed White, Head of Analytics, IP Group, Clarivate Analytics. "Large organizations that have traditionally dominated the innovation process must explore and embrace new ways of collaborating if they are to continue to thrive in a more complex and more fragmented ecosystem."

"Congratulations to the Top 100 Global Innovators, an excellent mix of organizations including many with extended legacies of driving innovation as well as those that have more recently pushed themselves to the forefront of today’s dynamic marketplace," said Jeff Roy, President, IP Group at Clarivate Analytics. "Together, they have built a culture of creating value based on ingenuity. And they have laid the bedrock for future innovation through the establishment and protection of their intellectual property.

Industry sector and regional snapshot
The Derwent Top 100 Global Innovators 2020 come from three continents and 14 countries/regions. The United States reclaimed the top spot with 39 organizations, followed by Japan with 32. Together, these two countries contributed almost three-quarters of this year’s Top 100 Global Innovators.

For industry sector representation, the Hardware & Electronics industries lead with 38 organizations, 3 more than last year, followed by Manufacturing & Medical with 16, and Telecoms and Software with 8 each.

Methodology
Now in its ninth year, Derwent Top 100 Global Innovators utilizes editorially enhanced, authoritative and accurate patent data from Derwent World Patents Index (DWPI) and Derwent Patent Citations Index (DPCI) to track innovation based on four indicators:

  1. Volume: The organization must have had at least 100 granted inventions (and more than 500 filed in total) in the past five years.
  2. Influence: The level of downstream impact by being highly cited externally by other organizations, and measured via the Derwent Patent Citations Index™ over the last five years, excluding citations from themselves.
  3. Success: A high ratio of success in obtaining patent grants.
  4. Globalization: The level of investment of a patent applicant in their invention, as tracked via the process of pursuing protection in all four of the key market patent offices of China, Europe, Japan, and the United States.

Additional findings and the full list of the Derwent Top 100 Global Innovators 2020 can be found here: https://clarivate.com/derwent/top100innovators/

About Derwent
Derwent™, a Clarivate Analytics company, powers the innovation lifecycle from idea to commercialization—with trusted patent data, applications and services including Derwent Innovation™, Derwent World Patents Index™, Derwent Patents Citation Index™ and Derwent Data Analyzer™. We build solutions for inventors, patent attorneys and licensing specialists at start-ups and the largest global innovators, legal professionals at the leading IP practices, and patent examiners at more than 40 patent offices. Our solutions are used to monitor technology trends and competitive landscapes, inform FTO opinions, prosecute patents, monetize and license assets and support litigation activities. For more information, please visit derwent.com.

About Clarivate Analytics                                  
Clarivate Analytics™ is a global leader in providing trusted insights and analytics to accelerate the pace of innovation. We have built some of the most trusted brands across the innovation lifecycle, including the Web of Science™, Cortellis™, Derwent™, CompuMark™, MarkMonitor™ and Techstreet™. Today, Clarivate Analytics™ is on a bold entrepreneurial mission to help customers reduce the time from new ideas to life-changing innovations. For more information, please visit www.clarivate.com.

Forward-Looking Statements
This press release and oral statements included herein may contain forward-looking statements regarding Clarivate Analytics. Forward-looking statements provide Clarivate Analytics’ current expectations or forecasts of future events and may include statements regarding results, anticipated synergies and other future expectations. These statements involve risks and uncertainties including factors outside of Clarivate Analytics’ control that may cause actual results to differ materially. Clarivate Analytics undertakes no obligation to update or revise the statements made herein, whether as a result of new information, future events or otherwise.

Clarivate and its logo, as well as all other trademarks used herein are trademarks of their respective owners and used under license.

Media Contacts
Sofia Nogués, Senior External Communications Manager
[email protected]

Jack Wan, Director of Communications for Asia Pacific
[email protected]

1 Based on patents added to Derwent World Patents Index (DWPI), of the annual Global Top 100 Innovators
2 Top 1,000 entities as ranked each year for the Derwent Top 100 Global Innovators program

Logo – https://mma.prnewswire.com/media/455613/clarivate_logo_for_press_release_Logo.jpg

Related Links :

Home

Are you a Corporate Representative of Clarivate Analytics, an investor, or a member of the Business Press?



From Intern to Digital Transformation Leader: HKBN Proudly Appoints Samuel Hui as Chief Transformation Officer

By | EN, PR

HONG KONG, Feb. 19, 2020 /PRNewswire/ — HKBN Group ("HKBN" or the "Group") is proud to announce that it has appointed Samuel Hui in a newly created role of Chief Transformation Officer ("CTO"), responsible for driving the Group’s digital transformation, enhancing overall customer experiences and helping enterprise partners transform digitally.

Looking to leverage technology, data analytics and most importantly, Talent ingenuity to create seamless digital experiences tailored around consumers, this appointment facilitates HKBN and its 6,000+ Talent-force to transform as a Group and deliver exceptional – and constantly evolving – customer experiences for great business results.

Transforming HKBN with fresh leadership vision

Samuel’s appointment as CTO follows HKBN’s recent high-profile appointments of Sam Tan as Chief Innovation Officer ("CIO"), and CY Chan as Chief Talent & Purpose Officer ("CT&PO"). By design, these three newly created roles embody HKBN’s commitment to unleash 180-degree change, enhancing all aspects of its business starting from Talent thinking, innovation, purpose, and Co-Ownership to automation, digitalisation, customer engagement strategies and new agile ways of working together. The Transformation office will preside over three Centers of Excellences – namely Digital, Big Data & AI, and IoT – working with key strategic partners and HKBN itself to architect and deliver impactful customer experiences and business transformations.

From intern to CTO

Samuel’s HKBN journey is an extraordinary one that began in 2008, when he joined as a summer intern. After earning dual Bachelor Degrees in Mechanical Engineering from Dartmouth College in the United States, Samuel further matured by joining leading New York-based management consulting firm, Oliver Wyman, advising senior executives on transformation strategies.

In 2016, Samuel was headhunted by HKBN to relocate back to Kwai Chung, Hong Kong and make a difference for our home. Despite being hired without a specific role, on his first day at work, Samuel was given the task of helping start HKBN Mobile Services. His team launched the new product in just four short months and grew the business to over 200,000 subscribers in its first year. Through this accomplishment, HKBN evolved into a ‘quad-play’ business, offering unprecedented value across broadband, telephone, OTT and mobile service. Shortly after, Samuel created a new digital customer referral programme for HKBN. Following this success, he was promoted to lead a team of digital specialists overseeing the Group’s multichannel customer experience, as well as digital engagement and CRM strategy across both B2C and B2B customers.

HKBN Co-Owner and Group CEO NiQ Lai said, "This appointment, together with our new CIO and new CT&PO, means we now have 2x Sams + a CY to ensure our transformation happens. At HKBN, we eat what we cook before we sell it, i.e. transform ourselves first before we help our partners do so for theirs."

HKBN Co-Owner and CTO Samuel Hui added, "Transformation starts with Talents, rather than with technology. My role will be to drive a quantum improvement rather than incremental gains to the business, to augment our Talents rather than to replace them, and to upgrade them from riding a horse to driving a Maserati."

From an intern in 2008 to the company’s youngest CXO in 2020, Samuel is set for the next big step to drive HKBN Group’s digital transformation.


From an intern in 2008 to the company’s youngest CXO in 2020, Samuel is set for the next big step to drive HKBN Group’s digital transformation.

 

Speaking at the world’s biggest “cloud carnival” at Dreamforce 2019, Samuel (right) shared HKBN’s digital transformation journey, highlighting how Talent, not technology, is the most important factor for transformation success.


Speaking at the world’s biggest “cloud carnival” at Dreamforce 2019, Samuel (right) shared HKBN’s digital transformation journey, highlighting how Talent, not technology, is the most important factor for transformation success.

 

About HKBN Group

HKBN Group ("HKBN" or the "Group"), headquartered in Hong Kong with operations spanning Asia across Hong Kong, Singapore, Malaysia, mainland China and Macau, is a leading integrated telecom and technology solutions provider. Through three core brands, Hong Kong Broadband Network, HKBN Enterprise Solutions and JOS, the Group offers comprehensive one-stop information and communications technology ("ICT") services that include broadband, data connectivity, managed Wi-Fi, integrated cloud solutions, information security, mobile, voice communications, IoT, big data, enterprise applications, data centre facilities, business continuity, system integration and OTT entertainment. HKBN’s tri-carrier fibre infrastructure in Hong Kong covers 2.4 million residential homes and over 7,200 commercial buildings and facilities. Committed to creating a lasting positive impact to wherever it operates, HKBN embraces a Core Purpose to "Make our Home a Better Place to Live". The Group is managed by hundreds of Co-Owners (supervisory and management level Talents in the Group) who invested their savings to buy shares of HKBN Ltd. (SEHK Stock Code: 1310). For more information about HKBN, please visit www.hkbn.net/en.

Photo – https://photos.prnasia.com/prnh/20200219/2724358-1-a?lang=0
Photo – https://photos.prnasia.com/prnh/20200219/2724358-1-b?lang=0
Logo – https://photos.prnasia.com/prnh/20190604/2486375-1LOGO?lang=0

Related Links :

http://www.hkbn.net/en

Are you a Corporate Representative of HKBN Group, an investor, or a member of the Business Press?



ZTE เปิดตัวโซลูชัน SuperDSS ใหม่สำหรับ Dynamic Spectrum Sharing แบบ Tri-RAT

By | PR, TH

เซินเจิ้น จีน–19 ก.พ.–พีอาร์นิวส์ไวร์/อินโฟเควสท์

ZTE Corporation (0763.HK / 000063.SZ) ผู้ให้บริการรายใหญ่ของโลกด้านโซลูชันโทรคมนาคมและเทคโนโลยีอินเทอร์เน็ตมือถือสำหรับองค์กรและผู้บริโภค เปิดตัวโซลูชัน SuperDSS ที่เป็นเอกลักษณ์ของอุตสาหกรรมสำหรับ dynamic spectrum sharing แบบ tri-RAT โดยโซลูชันนี้เป็นการยกระดับนวัตกรรมที่สำคัญของโซลูชัน Magic Radio Pro ในยุค 5G เพื่อให้สามารถทำการแชร์คลื่นความถี่แบบ multi-RAT ได้เมื่อนำย่านความถี่ FDD แบบดั้งเดิมมาจัดสรรใหม่ให้กับคลื่นความถี่ 5G ด้วยความสามารถของ dynamic spectrum sharing (DSS) ในกลุ่มคลื่นความถี่ 2G/4G/5G และคลื่นความถี่ 3G/4G/5G ทำให้ SuperDSS เป็นหนทางที่เหมาะสมสำหรับการใช้งาน 5G ความเร็วสูง และในเวลาเดียวกันก็ให้ประสบการณ์บริการเสียงแบบดั้งเดิมในช่วงย่านความถี่ 1800MHz หรือ 2100MHz เพื่อให้ได้คลื่นความถี่ที่ให้ผลตอบแทนจากการลงทุน (ROI) สูงที่สุด

ZTE ใช้ประโยชน์จากเทคโนโลยีที่ล้ำหน้าและประสบการณ์การใช้งานเชิงพาณิชย์ที่หลากหลายในส่วนของการใช้คลื่นความถี่ร่วมเพื่อเปิดตัวโซลูชัน dynamic spectrum sharing แบบ tri-RAT ในฐานะส่วนหนึ่งของโซลูชัน Magic Radio Pro ที่มีชื่อเสียง นอกจากนี้ ยังมีโซลูชันแบบ dual-RAT ซึ่งช่วยให้ผู้ให้บริการสามารถใช้งาน 5G ซึ่งเป็นนวัตกรรมเทคโนโลยีชั้นนำในด้านนี้ได้อีกครั้งด้วยความยืดหยุ่นกว่าเดิมมาก

โซลูชัน SuperDSS ของ ZTE รองรับการแชร์คลื่นความถี่เต็มรูปแบบทั้งในกลุ่ม 2G/4G/5G หรือ 3G/4G/5G ที่ใช้ย่านความถี่ 1800MHz หรือ 2100MHz ได้ในเวลาเดียวกัน ทั้งยังสามารถใช้งานได้กับย่านความถี่บนระบบ 2G หรือ 3G และมอบสเปตรัมมากสุดให้กับ LTE และ NR ซึ่งจะช่วยเพิ่มสมดุลให้กับการให้บริการเสียงแบบดั้งเดิมและบริการ 5G ยกตัวอย่างเช่น ปกติแล้ว การใช้งานแบนด์วิดท์ 20MHz จะต้องมีผู้ให้บริการ UMTS อย่างน้อยหนึ่งรายที่ถูกสงวนไว้สำหรับความต้องการด้านเสียงของผู้ใช้ UMTS จึงทำให้ 4G/5G DSS สามารถทำงานได้แค่บนแบนด์วิดท์ 15MHz เท่านั้น แต่สำหรับ ZTE SuperDSS แล้วทั้งคลื่นความถี่ 3G, 4G และ 5G สามารถแชร์กับแบนด์วิดท์ 20MHz ได้ทั้งหมด นอกจากนี้ ยังช่วยให้ผู้ให้บริการแบนด์วิดท์ UMTS สามารถปรับการทำงานได้แบบเรียลไทม์ตามความต้องการในขณะนั้นด้วย

โซลูชัน ZTE Magic Radio Pro ซึ่งเป็นโซลูชัน dynamic spectrum sharing แบบ multi-RAT ที่มีความครอบคลุมมากที่สุดในอุตสาหกรรม มอบความสามารถในการรับส่งข้อมูลแบบ dynamic spectrum sharing ได้สูงถึง 7 สถานการณ์ โดยใช้ประโยชน์จากการเข้าถึงเทคโนโลยีเครือข่าย 5 ตัว (GSM, UMTS, LTE, NB-IoT และ NR) ทั้งนี้ ZTE ในฐานะผู้นำนวัตกรรม ซึ่งสั่งสมประสบการณ์ในเรื่อง dynamic spectrum sharing แบบ multi-RAT มาตั้งแต่ปี 2557 จะเข้าไปช่วยเหลือผู้ให้บริการในการยกระดับประสบการณ์ลูกค้าและสร้างความสามารถการแข่งขันในตลาด ขณะเดียวกันก็จะผลักดันให้มีการเลิกใช้เทคโนโลยีล้าสมัยเพื่อเปลี่ยนเข้าสู่เฟสใหม่ของการใช้งานเทคโนโลยีที่ทันสมัยอย่างราบรื่น พร้อมปรับปรุงประสิทธิภาพการลงทุนของบรรดาผู้ให้บริการให้ดีขึ้นกว่าเดิม

ZTE คือผู้จัดหาระบบโทรคมนาคมที่ทันสมัย รวมถึงอุปกรณ์มือถือและโซลูชันเทคโนโลยีระดับองค์กรให้กับผู้บริโภค ผู้ให้บริการเครือข่าย บริษัท และลูกค้าระดับภาครัฐ ส่วนหนึ่งของกลยุทธ์ ZTE คือความมุ่งมั่นในการจัดหานวัตกรรมแบบบูรณาการและครบวงจรให้กับลูกค้า เพื่อมอบความเป็นเลิศและคุณค่าในขณะที่เซกเตอร์โทรคมนาคมและเทคโนโลยีสารสนเทศมาบรรจบกัน บริษัทจดทะเบียนในตลาดหุ้นฮ่องกงและเซินเจิ้น (รหัสหุ้นฮ่องกง: 0763.HK / รหัสหุ้นเซินเจิ้น: 000063.SZ) ZTE จำหน่ายผลิตภัณฑ์และบริการในกว่า 160 ประเทศทั่วโลก

สื่อติดต่อ:

Margaret Ma
ZTE Corporation
โทร: +86 755 26775189 
อีเมล: [email protected]

Related Links :

www.zte.com.cn

Are you a Corporate Representative of ZTE Corporation, an investor, or a member of the Business Press?



ZTE, 산업 고유의 SuperDSS 솔루션 출시

By | KR, PR

— 삼중 RAT 동적 스펙트럼 공유

(선전, 중국 2020년 2월 19일 PRNewswire=연합뉴스) 18일, 모바일 인터넷용 통신, 기업 및 소비자 기술 솔루션을 공급하는 세계 굴지의 기업 ZTE Corporation(0763.HK / 000063.SZ)이 SuperDSS 솔루션을 출시했다. SuperDSS는 삼중 RAT 동적 스펙트럼 공유를 위한 산업 고유의 솔루션이다. SuperDSS는 레거시 FDD 대역이 5G를 위해 리파밍되는 경우, 다중 RAT 스펙트럼 공유를 지원하는 5G 시대 Magic Radio Pro 솔루션으로 향하는 중대한 혁신 단계다. 2G/4G/5G와 3G/4G/5G 사이에서 동적 스펙트럼 공유를 지원하는 SuperDSS는 신속한 5G 설치를 위한 이상적인 방식인 동시에 스펙트럼 투자 수익을 최대화하기 위해 1800~2100MHz 대역에서 레거시 음성 서비스 경험도 제공한다.

ZTE는 자사의 유명한 Magic Radio Pro 솔루션에서 듀얼 RAT 솔루션에 이어 이 삼중 RAT 동적 스펙트럼 공유 솔루션을 출시하고자 스펙트럼 분야에서 자사의 첨단 기술과 풍부한 상업적 설치 경험을 활용했다. 이를 통해 통신사에 훨씬 더 높은 5G 설치 유연성을 제공하고, 이 분야에서 다시 한번 기술 혁신을 주도하게 됐다.

ZTE의 SuperDSS는 수요 발생 시 2G나 3G에 의한 스펙트럼 이용을 위해 1800~2100MHz 대역과 동시에 2G/4G/5G ~ 3G/4G/5G 완전 동적 공유도 지원한다. 또한, LET와 NR을 위해 가능한 한 많은 스펙트럼 자원을 제공한다. 그 결과 최상의 균형을 기반으로 레거시 음성 서비스와 5G 서비스도 제공한다. 20MHz 대역폭을 예로 들면, UMTS 사용자 음성 요건을 위해 최소 하나의 UMTS 캐리어를 확보해야 한다. 따라서 4G/5G DSS는 오직 15MHz 대역폭에서만 기능을 수행한다. ZTE SuperDSS, 3G, 4G 및 5G는 모든 20MHz 대역폭을 공유할 수 있으며, UMTS 캐리어 대역폭은 서비스 요건에 따라 실시간으로 조정할 수 있다.

ZTE Magic Radio Pro 솔루션은 업계에서 가장 포괄적인 다중 RAT 동적 스펙트럼 공유 솔루션으로서 5가지 무선 접속 기술(GSM, UMTS, LTE, NB-IoT 및 NR)로 최대 7가지 시나리오를 위한 동적 스펙트럼 공유를 제공한다. 이 분야에서 혁신 선두주자인 ZTE는 2014년부터 풍부한 다중 RAT 동적 스펙트럼 공유 경험을 축적했으며, 통신사가 사용자 경험과 시장 경쟁력을 높이도록 지원하는 한편, 레거시 기술의 원활한 단계적 폐지와 통신사의 투자 효율성을 크게 높일 신기술의 원활한 단계적 도입을 촉진해왔다.

ZTE는 소비자, 통신사, 기업 및 공공 부문 고객에게 첨단 통신 시스템, 모바일 장치 및 기업 기술 솔루션을 제공한다. 통신과 정보기술 부문이 통합하는 가운데, ZTE는 회사 전략의 일환으로 우수성과 가치를 제공하는 포괄적인 통합 혁신을 고객에게 제공하는 데 전념하고 있다. 홍콩과 선전 증권거래소(H 주식 코드: 0763.HK / A 주식 코드: 000063.SZ)에 상장된 ZTE의 제품과 서비스는 160개국 이상에서 판매되고 있다.

미디어 문의:

Margaret Ma
ZTE Corporation
전화: +86 755 26775189 
이메일: [email protected]

출처: ZTE Corporation

Related Links :

www.zte.com.cn

Are you a Corporate Representative of ZTE Corporation, an investor, or a member of the Business Press?



新思科技完成对INVECAS部分IP资产的收购

By | PR, SC

加州山景城2020年2月19日 /美通社/ — 新思科技(Synopsys, Inc.,纳斯达克股票代码:SNPS)近日宣布已完成对INVECAS部分IP资产的收购。此次收购不仅扩大了新思科技DesignWare®逻辑库、嵌入式存储器、通用I/O、模拟和接口IP产品组合,还带来了一支经验丰富的研发工程师团队,有助于加快新思科技在众多工艺技术上的物理IP核开发,满足消费、物联网和汽车等市场中客户不断变化的设计需求。INVECAS将保留其HDMI IP和ASIC设计解决方案。

这项交易不会对新思科技的财务状况产生重大影响,交易条款未披露。

DesignWare IP核简介

新思科技是面向芯片设计提供高质量硅验证IP核解决方案的领先供应商。DesignWare IP核组合包括逻辑库、嵌入式存储器、嵌入式测试、模拟IP、有线和无线接口IP、安全IP、嵌入式处理器和子系统。为了加速原型设计、软件开发以及将IP整合进芯片,新思科技IP Accelerated计划提供IP原型设计套件、IP软件开发套件和IP子系统。新思科技对IP核质量的广泛投资、全面的技术支持以及强大的IP开发方法使设计人员能够降低整合风险,并加快上市时间。垂询DesignWare IP核详情,请访问www.synopsys.com/designware

新思科技简介

新思科技(Synopsys, Inc.,纳斯达克股票代码:SNPS)是众多创新型公司的Silicon to Software™(“芯片到软件”)合作伙伴,这些公司致力于开发我们日常所依赖的电子产品和软件应用。作为全球第15大软件公司,新思科技长期以来一直是电子设计自动化(EDA)和半导体IP领域的全球领导者,并且在软件安全和质量解决方案方面也发挥着越来越大的领导作用。无论您是创建高级半导体的片上系统(SoC)设计人员,还是编写需要最高安全性和质量的应用程序的软件开发人员,新思科技都能够提供您所需要的解决方案,帮助您推出创新性的、高质量的、安全的产品。有关更多信息,请访问www.synopsys.com/

编辑联系人:
Camille Xu
新思科技
电邮:[email protected]

Simone Souza
新思科技
电邮:[email protected]

投资者联系人:
Lisa Ewbank
新思科技
电邮:[email protected]

相关链接 :

http://www.synopsys.com

https://www.synopsys.com/zh-cn

Are you a Corporate Representative of Synopsys, Inc., an investor, or a member of the Business Press?



复宏汉霖召开第四次科学顾问委员会会议

By | PR, SC

上海2020年2月18日 /美通社/ — 复宏汉霖(香港联交所代码:2696)于近日召开了第四次科学顾问委员会(Scientific Advisory Board, SAB)会议。本次SAB会议在美国旧金山湾区召开,这里汇集了众多高科技企业和知名科研院所,也是复宏汉霖美国研发中心所在地。

复宏汉霖第四次科学顾问委员会


复宏汉霖第四次科学顾问委员会

为了能够及时了解国际上癌症和自身免疫性疾病治疗领域中最前沿的研究进展与趋势,与领域内顶尖学者进行深度交流,听取他们的专业建议,复宏汉霖于2018年正式成立了由外部杰出科学家组成的SAB,并定期邀请SAB成员与复宏汉霖上海、台北和加州等三地研发中心的代表以及特邀外部科学家召开SAB会议。每次SAB的召开,都可谓是集结了复宏汉霖内外部的“最强大脑”,着实引人关注。

在此次SAB会议上,与会的科学家们主要围绕公司进展较快的研发项目进行了讨论,讨论内容则涵盖了项目的科学支撑依据、竞争格局、最新研发数据和未来计划等方面。SAB专家成员和特邀嘉宾对于公司丰富的研发管线、研发项目的差异化和作用机制的多样性以及关键项目的快速推进表达了高度认可;同时,也对不同研发项目的优先级设置、研发资源分配以及相关生物学内容提出了建设性的意见。

复宏汉霖联合创始人、首席执行官刘世高博士在会议开始简要介绍了复宏汉霖的使命与愿景、发展历程与策略、商业化计划与致力于创新研发的决心。随后,复宏汉霖高级副总裁、首席医学官陆英明博士就临床开发策略与管线进行了总体的概述,并特别针对抗PD-1单抗HLX10相关临床项目进行了重点介绍。

复宏汉霖抗PD-1单抗HLX10临床研发进展


复宏汉霖抗PD-1单抗HLX10临床研发进展

此次SAB会议的特邀嘉宾 — 斯坦福大学医学院肿瘤科医学教授 Ron Levy 围绕靶向肿瘤的抗体疗法和作用于免疫系统的原位疫苗相关研究进展进行了讲解。多年来,Ron Levy 教授一直悉心钻研如何利用免疫系统对抗癌症,并取得了卓著的成果。正是他的开创性工作,造就了首个获得美国FDA批准用于癌症治疗的单克隆抗体药物利妥昔单抗。巧合的是,首个在中国获批的生物类似药恰恰也是利妥昔单抗(商品名:汉利康®),汉利康®也是复宏汉霖首个获批上市的产品。近年来,Ron Levy 教授实验室在抗肿瘤原位疫苗方面的研究也取得了多项突破性的进展,吸引了极大的关注。

在SAB会议上,Ron Levy 教授表示:“生物医药公司与学术科研界的合作非常值得鼓励,有利于分别发挥双方在药物开发和生物学理解上的优势。”

Ron Levy 教授的这一观点也普遍获得了参加本次会议的SAB专家成员、其他特邀嘉宾和复宏汉霖与会人员的高度认同。目前复宏汉霖也在积极推动多项与国内外知名院校或科研机构的合作项目。会议最后,与会的科学家们就一系列研发相关具体问题展开了深入的讨论,并对研发重心和合作的重要性进行了强调。

SAB主席管坤良教授在会后评价道:“这次SAB会议信息量大,卓有成效。看到复宏汉霖研发项目取得了如此之大的进展,我们都非常高兴。让我们趁热打铁,尽快敲定下一次SAB会议。”

SAB专家成员李子海教授认为:“此次会议堪称‘现象级’,复宏汉霖研发项目的进展令人印象深刻。复宏汉霖研发团队对创新展现出了高度的专注,是一支非常具有活力的团队。相信这样的团队必将取得令人瞩目的成绩。”

由于大家对于SAB会议效果的评价非常积极,同时考虑到公司研发项目的快速推进,本次会议还决定增加SAB会议频率,以便更加及时地吸取SAB对于研发项目的专业意见,并初步决定下一次SAB会议将于2020年年中召开。

对创新的追求和热情、对彼此的认可与信赖将这些“最强大脑“集结。未来,他们将继续保持深度的沟通交流和思维碰撞,不断地在研发策略和技术攻关等方面为复宏汉霖提供指导。

复宏汉霖科学顾问委员会专家成员简介

管坤良博士,Kun-Liang Guan, Ph.D.
复宏汉霖科学顾问委员会主席
加州大学圣地亚哥分校药理学杰出教授

管博士拥有普渡大学博士学位,1992-2007期间,管博士执教于密歇根大学。管博士专注于细胞生长和肿瘤发生的信号机制研究,尤其关注mTOR和Hippo通路。管博士曾获“麦克阿瑟”奖,并被授予美国生物化学与分子生物学协会青年研究员奖,普渡大学杰出校友称号。同时,管博士作为美国科学促进会会士,也是分子生物学和遗传学领域的高被引研究者。

杨一平博士
Yiping Yang, M.D., Ph.D.
美国俄亥俄州立大学血液科主任,医学教授
《临床研究杂志》JCI、JCI Insight副主编

杨博士拥有密歇根大学博士学位,是获得美国内科学委员会认证的淋巴瘤、白血病临床医生。自2008年以来,杨博士一直被评选为美国顶级的肿瘤学家。杨博士专注于免疫学领域的研究,涵盖肿瘤免疫学、免疫疗法、基因疗法以及病毒免疫学,其研究项目获得美国国立卫生研究院和私人基金的资助。杨博士累计在《科学》、《自然免疫学》、《自然遗传学》、《自然医学》、《免疫》、JCI、PNAS等期刊上发表超过100篇同行评议的论文。

邹伟平博士
Weiping Zou, Ph.D.
美国密歇根大学医学院Charles B. de Nancrede外科教授
美国密歇根大学医学院肿瘤免疫与免疫治疗中心主任

邹博士现执教于密歇根大学。邹博士致力于肿瘤免疫病理学和免疫治疗的研究,在过去的几年中,他带领团队在肿瘤免疫发病机制领域取得重要进展,其研究发现对于确定肿瘤微环境中的免疫反应本质具有重要作用,同时他还提出了肿瘤微环境中免疫抑制网络的概念。邹博士的团队也是肿瘤免疫学领域中被引用最多的团队之一。邹博士是九家学术期刊的编委会成员,曾主讲过200多次专业讲座。同时,邹博士还是包括NIH和DOD在内的15家资助机构以及包括《新英格兰医学杂志》、《细胞》、《科学》和《自然杂志》在内的50多家学术期刊的审稿人。邹博士当选为2018-2019届美国肿瘤研究协会肿瘤免疫学主席。

李子海博士
Zihai Li, M.D., Ph.D.
美国俄亥俄州大学(OSU)克洛茨癌症研究纪念讲席教授
James 综合肿瘤中心Pelotonia肿瘤免疫研究所创始所长
中国临床肿瘤协会(CSCO)海外专家协会首任主委

李子海教授拥有美国纽约西奈山医学院微生物和免疫学博士学位,并持有美国医师资格证书,同时也是美国内科协会指定认可的肿瘤学专家。之前,李子海教授曾任职于美国南卡罗莱纳医科大学(MUSC)与Hollings癌症中心。李教授课题组主要从事肿瘤免疫治疗,包括调节性T细胞生物学、先天免疫、热休克蛋白疫苗及其生物学等方面的研究并取得卓越的成果,他是gp96/grp94分子伴侣领域研发领军人物,也极大地推进了热休克蛋白肿瘤疫苗相关研究,最近首次证明血小板及GARP-TGFb分子轴在肿瘤免疫中的重要性,同时提出并证明CNPY2分子在内质网应激信号传递的新理论。李子海教授的研究近20年一直受到美国国立卫生研究院NIH基金的支持。

关于复宏汉霖科学顾问委员会

复宏汉霖科学顾问委员会成立于2018年5月,委员会主席管坤良教授,顾问杨一平教授、邹伟平教授和李子海教授皆为肿瘤生物学、免疫学、癌症治疗领域的杰出科学家或医生。各位科学顾问不仅在公司研发战略方面给予专业指导意见,更为抗体产品的开发与技术攻关提供指导,协助开发更多疗效佳、可负担的靶向药物,进一步完善复宏汉霖的现有产品管线,为新一代免疫疗法开创更多的组合治疗方案。

关于复宏汉霖

复宏汉霖(2696.HK)是一家中国领先的生物制药公司,旨在为全球患者提供质高价优的创新生物药,产品覆盖肿瘤、自身免疫性疾病等领域。自2010年成立以来,公司以全球联动、整合创新为产品开发理念,在中国上海、中国台北和美国加州均设有研发中心,具备了协同增效的突出优势。复宏汉霖主要的产品开发策略是仿创结合,从生物类似药起步,逐步开发创新型单抗产品,结合自主开发的抗PD-1和PD-L1单抗,在国内率先推出免疫联合疗法,前瞻性布局了一个多元化、创新单抗及肿瘤免疫联合疗法管线,打造出研究、开发、商业化生产的综合性生物医药全产业链平台。2019年9月25日,复宏汉霖在香港联合交易所有限公司主板上市,股票代码:2696.HK。

截至目前,复宏汉霖已有1个产品成功上市,2个产品获得中国新药上市申请受理,1个产品获得欧盟新药上市申请受理,14个产品、7个联合治疗方案在全球范围内开展20多项临床试验。其中,公司首款重磅产品汉利康®(利妥昔单抗注射液)于2019年2月获国家药监局新药上市注册批准,成为中国首个获批上市的生物类似药。HLX03(阿达木单抗注射液)与HLX02(注射用曲妥珠单抗)已获国家药监局新药上市申请受理,现已纳入优先审评程序。HLX02相继在中国大陆、乌克兰、欧盟波兰和菲律宾全面启动国际多中心3期临床试验,成为国内首个开展国际多中心3期临床研究的生物类似药,并于2019年6月获欧洲药品管理局上市申请受理。此外,公司已陆续就HLX10与自有产品HLX04(贝伐珠单抗生物类似药)、HLX07(抗EGFR单抗)以及化疗联用开展多项肿瘤免疫联合疗法,在全球范围内开展多个临床研究。

Are you a Corporate Representative of 复宏汉霖, an investor, or a member of the Business Press?



Synopsys Completes Acquisition of Certain IP Assets from INVECAS

By | EN, PR

MOUNTAIN VIEW, California, Feb. 19, 2020 /PRNewswire/ — Synopsys, Inc. (Nasdaq: SNPS) today announced that it has completed its acquisition of certain IP assets from INVECAS. This acquisition broadens Synopsys’ DesignWare® Logic Library, Embedded Memory, General Purpose I/O, Analog, and Interface IP portfolio. The acquisition also adds a team of experienced R&D engineers to accelerate Synopsys’ physical IP roadmap across a range of process technologies to address customers’ evolving design requirements in markets such as consumer, IoT and automotive. INVECAS will retain its HDMI IP and ASIC Design Solutions.

The transaction is not material to Synopsys’ financials and the terms are not being disclosed.  

About DesignWare IP

Synopsys is a leading provider of high-quality, silicon-proven IP solutions for SoC designs. The broad DesignWare® IP portfolio includes logic libraries, embedded memories, embedded test, analog IP, wired and wireless interface IP, security IP, embedded processors and subsystems. To accelerate prototyping, software development and integration of IP into SoCs, Synopsys’ IP Accelerated initiative offers IP prototyping kits, IP software development kits and IP subsystems. Synopsys’ extensive investment in IP quality, comprehensive technical support and robust IP development methodology enable designers to reduce integration risk and accelerate time-to-market. For more information on DesignWare IP, visit www.synopsys.com/designware.

About Synopsys

Synopsys, Inc. (Nasdaq: SNPS) is the Silicon to Software™ partner for innovative companies developing the electronic products and software applications we rely on every day. As the world’s 15th largest software company, Synopsys has a long history of being a global leader in electronic design automation (EDA) and semiconductor IP and is also growing its leadership in software security and quality solutions. Whether you’re a system-on-chip (SoC) designer creating advanced semiconductors, or a software developer writing applications that require the highest security and quality, Synopsys has the solutions needed to deliver innovative, high-quality, secure products. Learn more at www.synopsys.com/.  

Editorial Contacts:
Camille Xu
Synopsys, Inc.
[email protected]

Simone Souza
Synopsys, Inc.
[email protected]

Investor Contact:
Lisa Ewbank
Synopsys, Inc.   
[email protected]

 

Related Links :

http://www.synopsys.com

https://www.synopsys.com/zh-cn

Are you a Corporate Representative of Synopsys, Inc., an investor, or a member of the Business Press?



VolitionRx Limited Schedules Full Year 2019 Earnings Conference Call and Business Update

By | EN, PR

Conference call to take place Friday, February 21, 2019 at 8:30 am Eastern time

AUSTIN, Texas, Feb. 19, 2020 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on Friday, February 21 at 8:30 a.m. Eastern time to discuss its financial and operating results for the fourth quarter and full year 2019, in conjunction with the filing of its annual report on Form 10-K for the fourth quarter and full year ended December 31, 2019.

Event: VolitionRx Limited Fourth Quarter & Full Year 2019 Earnings and Business Update Conference Call
Date: Friday, February 21, 2020
Time: 8:30 a.m. Eastern time
U.S. & Canada Dial-in: 1-877-407-9716 (toll free)
U.K. Dial-in: 0 800 756 3429 (toll free)
Toll/International: 1-201-493-6779
Conference ID:  13699351

Cameron Reynolds, President and Chief Executive Officer of Volition, will host the call along with David Vanston, Chief Financial Officer and Scott Powell, Executive Vice President, Investor Relations. The call will provide an update on recent developments and Volition’s activities, including details of new and ongoing clinical trials, important events which have taken place in 2019, and milestones for 2020 and beyond.

A live audio webcast of the conference call will also be available on the investor relations page of Volition’s corporate website at http://ir.volition.com. In addition, a telephone replay of the call will be available until March 6, 2020. The replay dial-in numbers are 1-844-512-2921 (toll-free) in the U.S. and Canada and 1-412-317-6671 (toll) internationally. Please use replay pin number 13699351.

About Volition

Volition is a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potential to not only prolong the life of patients, but also to improve their quality of life. The tests are based on the science of Nucleosomics(TM), which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid – an indication that disease is present. Volition is primarily focused on human diagnostics but also has a subsidiary focused on animal diagnostics.

Volition’s research and development activities are centered in Belgium, with additional offices in Texas, London and Singapore, as the company focuses on bringing its diagnostic products to market.

Nucleosomics(TM) is a trademark of Volition and its subsidiaries.

For more information about Volition, visit Volition’s website (http://www.volition.com) or connect with us via:

Twitter: https://twitter.com/volitionrx
LinkedIn: https://www.linkedin.com/company/volitionrx
Facebook: https://www.facebook.com/VolitionRx/
YouTube: https://www.youtube.com/user/VolitionRx

The contents found at Volition’s website address, Twitter, LinkedIn, Facebook, and YouTube are not incorporated by reference into this document and should not be considered part of this document.  The addresses for Volition’s website, Twitter, LinkedIn, Facebook, and YouTube are included in this document as inactive textual references only.

Media / Investor Contacts

Louise Batchelor, Volition

[email protected]

+44 (0)7557 774620

Scott Powell, Volition

[email protected]

+1 (646) 650 1351

Joseph Green, Edison Advisors

[email protected]

+1 (646) 653 7030

 

Cision View original content:http://www.prnewswire.com/news-releases/volitionrx-limited-schedules-full-year-2019-earnings-conference-call-and-business-update-301006813.html

Related Links :

http://www.volitionrx.com

Are you a Corporate Representative of VolitionRx Ltd, an investor, or a member of the Business Press?



China XD Plastics Company Limited Regains Compliance With NASDAQ Annual Meeting Requirement

By | EN, PR

HARBIN, China, Feb. 18, 2020 /PRNewswire/ — China XD Plastics Company Limited (NASDAQ: CXDC) ("China XD Plastics" or the "Company"), one of China’s leading specialty chemical companies engaged in the development, manufacture and sale of polymer composite materials primarily for automotive applications, today announced that it has received the formal notification from the Listing Qualifications Department of The NASDAQ Stock Market ("NASDAQ") on February 13, 2020, informing the Company that it now complies with Listing Rule 5620, which requires that the Company holds an annual meeting of shareholders within twelve months after the end of a company’s financial year.

On January 2, 2020, NASDAQ notified the Company that it did not comply with Listing Rule 5620. On February 11, 2020, the Company held its annual meeting of shareholders.

About China XD Plastics Company Limited

China XD Plastics Company Limited, through its wholly-owned subsidiaries, develops, manufactures and sells polymer composites materials, primarily for automotive applications. The Company’s products are used in the exterior and interior trim and in the functional components of 31 automobile brands manufactured in China, including without limitation, AUDI, Mercedes Benz, BMW, Toyota, Buick, Chevrolet, Mazda, Volvo, Ford, Citroen, Jinbei and VW Passat, Golf, Jetta, etc. The Company’s wholly-owned research center is dedicated to the research and development of polymer composites materials and benefits from its cooperation with well-known scientists from prestigious universities in China. As of September 30, 2019, 601 of the Company’s products have been certified for use by one or more of the automobile manufacturers in China. For more information, please visit the Company’s English website at http://www.chinaxd.net, and the Chinese website at http://www.xdholding.com.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact in this announcement are forward-looking statements, including but not limited to, the Company’s growth potential in international markets; the effectiveness and profitability of the Company’s product diversification strategy; the impact of the Company’s product mix shift to more advanced products and related pricing policies;  the effectiveness, profitability, and the marketability of its the ongoing mix shift to more advanced products; the prospect of the Company’s Dubai facility, and the associated expansion into Middle East, Europe and other parts of Asia; the prospect of the Company’s Southwest China facility, the prospects of the Company’s Harbin facility, and its penetration into Northeast China; and its penetration into Southwest China; the Company’s projections of its revenues for performance in fiscal 2019.   These forward-looking statements can be identified by terminology such as "will," "expect," "project," "anticipate," "forecast," "plan," "believe," "estimate" and similar statements. Forward-looking statements involve inherent risks and uncertainties and are based on current expectations, assumptions, estimates and projections about the Company and the industry. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Potential risks and uncertainties include, but are not limited to, the global economic uncertainty could further impair the automotive industry and limit demand for our products; fluctuations in automotive sales and production could have a material adverse effect on our results of operations and liquidity; our financial performance may be affected by the prospect of our Dubai facility and the associated expansion into Middle East, Europe and other parts of Asia; the withdrawal of preferential government policies and the tightening control over the Chinese automotive industry and automobile purchase restrictions imposed in certain major cities may limit market demand for our products; the slowing of Chinese automotive industry’s growth; the concentration of our distributors, customers and suppliers; and other risks detailed in the Company’s filings with the Securities and Exchange Commission and available on its website at http://www.sec.gov. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or to changes in its expectations, except as may be required by law.  Although the Company believes that the expectations expressed in these forward looking statements are reasonable, it cannot assure you that its expectations will turn out to be correct, and investors are cautioned that actual results may differ materially from the anticipated results.

 

Cision View original content:http://www.prnewswire.com/news-releases/china-xd-plastics-company-limited-regains-compliance-with-nasdaq-annual-meeting-requirement-301006605.html

Related Links :

http://www.xdholding.com

Are you a Corporate Representative of China XD Plastics Company Limited, an investor, or a member of the Business Press?